...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
【24h】

Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.

机译:大麻素CB(2)受体激活可防止在胃食管反流模型中支气管收缩和气道水肿。

获取原文
获取原文并翻译 | 示例

摘要

Cannabinoids have been shown to inhibit sensory nerve activation in guinea-pigs and humans. Their effects are mediated by specific activation of two types of receptors, named CB(1) and CB(2). The purpose of this study was to investigate the effects of WIN 55,212-2, (R)-(+)-[2,3-dihydro-5methyl-3-[(4-morpholino)methyl]pyrrolo-[1,2,3-de]-1,4-benzo xazin-6-yl](1-naphthyl)methanone, a non selective agonist of cannabinoid receptors, and JWH 133, (6aR,10aR)-3-(1,1-dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenz o[b,d]pyran a selective cannabinoid CB(2) receptor agonist, on the sensory nerve component of intraoesophageal (i.oe.) HCl-induced airway microvascular leakage and bronchoconstriction in guinea-pigs. We also tested the effect of WIN 55,212-2 on substance P-induced plasma extravasation and bronchoconstriction. Airway microvascular leakage and bronchoconstriction induced by i.oe. HCl was inhibited by the cannabinoid CB(1)/CB(2) agonist WIN 55,212-2 (0.3-3 mg/kg i.p.) in a dose-dependent manner (maximal inhibition at the dose of 3 mg kg(-1), P<0.01). The effect of WIN 55,212-2 was inhibited by a cannabinoid CB(2) receptor antagonist SR 144528, [N-[(1S)-endo-1,3,3-trimethylbicyclo[2,2,1] heptan-2yl]-5-(-4-chloro-3-methylphenyl)-1-(4-methylbenzyl)pyrazole-3-carboxamide ], but not by a CB(1) receptor antagonist, SR 141716, [N-(piperidin-1yl)-5-(-4-chlorophenyl)-1-(2,4dichlorophenyl)-4-methyl-1H-pyrazole -3-carboxamide hydrochloride]. The cannabinoid CB(2) agonist JWH 133 (0.3-3 mg/kg i.p.) mimicked the inhibitory effect of WIN 55,212-2 on HCl-induced microvascular leakage. Under similar conditions, WIN 55,212-2 (1 mg kg (-1) i.p.) was unable to counteract the airway microvascular leakage and bronchoconstriction induced by substance P. These results suggest that inhibition by WIN 55,212-2 of airway plasma extravasation and bronchoconstriction induced by i.oe. HCl instillation in guinea-pigs is mediated through cannabinoid CB(2) receptor activation.
机译:大麻素已显示可抑制豚鼠和人的感觉神经激活。它们的作用由两种类型的受体CB(1)和CB(2)的特异性激活介导。这项研究的目的是研究WIN 55,212-2,(R)-(+)-[2,3-二氢-5甲基-3-[(4-吗啉代)甲基]吡咯并-[1,2,大麻素受体的非选择性激动剂3-de] -1,4-苯并恶嗪-6-基](1-萘基)甲酮和JWH 133,(6aR,10aR)-3-(1,1-二甲基丁基) -6a,7,10,10a-tetrahydro-6,6,9-三甲基-6H-dibenz o [b,d] pyran是一种选择性大麻素CB(2)受体激动剂,位于食道内(i.oe)的感觉神经上。)HCl诱导豚鼠的气道微血管渗漏和支气管收缩。我们还测试了WIN 55,212-2对P物质诱导的血浆外渗和支气管收缩的作用。 i.oe引起的气道微血管渗漏和支气管收缩。 HCl被大麻素CB(1)/ CB(2)激动剂WIN 55,212-2(0.3-3 mg / kg ip)抑制,呈剂量依赖性(在3 mg kg(-1)剂量下具有最大抑制作用, P <0.01)。大麻类CB(2)受体拮抗剂SR 144528,[N-[(1S)-endo-1,3,3-trimethylbicyclobi [2,2,1] heptan-2yl]-抑制WIN 55,212-2的作用5-(-4-氯-3-甲基苯基)-1-(4-甲基苄基)吡唑-3-甲酰胺,但不是由CB(1)受体拮抗剂SR 141716,[N-(哌啶-1-基)- 5-(-4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-羧酰胺盐酸盐]。大麻素CB(2)激动剂JWH 133(0.3-3 mg / kg i.p.)模仿了WIN 55,212-2对HCl诱导的微血管渗漏的抑制作用。在类似条件下,WIN 55,212-2(1 mg kg(-1)ip ip)无法抵消P物质引起的气道微血管渗漏和支气管收缩。这些结果表明,WIN 55,212-2对气道血浆外渗和支气管收缩的抑制作用由i.oe。豚鼠的HCl滴注是通过大麻素CB(2)受体激活而介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号